BEVACIZUMAB (BEV), IRINOTECAN (IRI), FOLINIC ACID (FA) AND FLUOROURACIL (FU) EVERY 2 WEEKS (BIFF REGIMEN) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS): THE SOUTHERN ITALY COOPERATIVE ONCOLOGY GROUP (SICOG) EXPERIENCE